Thursday, March 24, 2011
Boston Scientific wins FDA nod for back pain device
Boston Scientific Corporation (NYSE:BSX) has announced that the U.S. Food and Drug Administration has approved a new version of its rechargeable device designed to address chronic back pain.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment